• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于在显性播散性血管内凝血进展到显性阶段之前进行早期准确预测的机器学习模型。

A machine learning model for early and accurate prediction of overt disseminated intravascular coagulation before its progression to an overt stage.

作者信息

Umemura Yutaka, Okada Naoki, Ogura Hiroshi, Oda Jun, Fujimi Satoshi

机构信息

Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan.

Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

出版信息

Res Pract Thromb Haemost. 2024 Jul 22;8(5):102519. doi: 10.1016/j.rpth.2024.102519. eCollection 2024 Jul.

DOI:10.1016/j.rpth.2024.102519
PMID:39221450
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11363840/
Abstract

BACKGROUND

Recent studies suggested an expected survival benefit associated with anticoagulant therapies for sepsis in patients with disseminated intravascular coagulation (DIC). However, anticoagulant therapies for overt DIC are no longer assumed to regulate pathologic progression as overt DIC is a late-phase coagulation disorder. Therefore, methods for early prediction of sepsis-induced DIC before its progression to an overt stage are strongly required.

OBJECTIVES

We aimed to develop a prediction model for overt DIC using machine learning.

METHODS

This retrospective, observational study included adult septic patients without overt DIC. The objective variable was binary classification of whether patients developed overt DIC based on International Society on Thrombosis and Haemostasis (ISTH) overt DIC criteria. Explanatory variables were the baseline and time series data within 7 days from sepsis diagnosis. Light Gradient Boosted Machine method was used to construct the prediction model. For controls, we assessed sensitivity and specificity of Japanese Association for Acute Medicine DIC criteria and ISTH sepsis-induced coagulopathy criteria for subsequent onset of overt DIC.

RESULTS

Among 912 patients with sepsis, 139 patients developed overt DIC within 7 days from diagnosis of sepsis. Sensitivity, specificity, and area under the receiver operating characteristic curve for predicting onset of overt DIC within 7 days were 84.4%, 87.5%, and 0.867 in the test cohort and 95.0%, 75.9%, and 0.851 in the validation cohort, respectively. Sensitivity and specificity by the diagnostic thresholds were 54.7% and 74.9% for Japanese Association for Acute Medicine DIC criteria and 63.3% and 71.9% for ISTH sepsis-induced coagulopathy criteria, respectively.

CONCLUSION

Compared with conventional DIC scoring systems, a machine learning model might exhibit higher prediction accuracy.

摘要

背景

近期研究表明,对于弥散性血管内凝血(DIC)患者,抗凝治疗对脓毒症具有预期的生存益处。然而,由于显性DIC是一种晚期凝血障碍,不再认为抗凝治疗能调节其病理进展。因此,迫切需要在脓毒症诱导的DIC进展到显性阶段之前对其进行早期预测的方法。

目的

我们旨在使用机器学习开发一种显性DIC的预测模型。

方法

这项回顾性观察研究纳入了无显性DIC的成年脓毒症患者。目标变量是根据国际血栓与止血学会(ISTH)显性DIC标准对患者是否发生显性DIC进行二分类。解释变量是脓毒症诊断后7天内的基线和时间序列数据。使用轻梯度提升机方法构建预测模型。作为对照,我们评估了日本急性医学协会DIC标准和ISTH脓毒症诱导的凝血病标准对随后发生显性DIC的敏感性和特异性。

结果

在912例脓毒症患者中,139例在脓毒症诊断后7天内发生显性DIC。在测试队列中,预测7天内显性DIC发作的敏感性、特异性和受试者工作特征曲线下面积分别为84.4%、87.5%和0.867,在验证队列中分别为95.0%、75.9%和0.851。日本急性医学协会DIC标准的诊断阈值的敏感性和特异性分别为54.7%和74.9%,ISTH脓毒症诱导的凝血病标准的敏感性和特异性分别为63.3%和71.9%。

结论

与传统的DIC评分系统相比,机器学习模型可能具有更高的预测准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f171/11363840/5889fd014192/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f171/11363840/5daa89554ccb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f171/11363840/cc332f01ba86/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f171/11363840/c72059e7aede/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f171/11363840/5889fd014192/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f171/11363840/5daa89554ccb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f171/11363840/cc332f01ba86/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f171/11363840/c72059e7aede/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f171/11363840/5889fd014192/gr4.jpg

相似文献

1
A machine learning model for early and accurate prediction of overt disseminated intravascular coagulation before its progression to an overt stage.一种用于在显性播散性血管内凝血进展到显性阶段之前进行早期准确预测的机器学习模型。
Res Pract Thromb Haemost. 2024 Jul 22;8(5):102519. doi: 10.1016/j.rpth.2024.102519. eCollection 2024 Jul.
2
Diagnosis of sepsis-induced disseminated intravascular coagulation and coagulopathy.脓毒症诱导的弥散性血管内凝血及凝血病的诊断
Acute Med Surg. 2019 Apr 1;6(3):223-232. doi: 10.1002/ams2.411. eCollection 2019 Jul.
3
Newly Proposed Sepsis-Induced Coagulopathy Precedes International Society on Thrombosis and Haemostasis Overt-Disseminated Intravascular Coagulation and Predicts High Mortality.新提出的脓毒症诱导性凝血病先于国际血栓与止血学会弥漫性血管内凝血,并预测高死亡率。
J Intensive Care Med. 2020 Jul;35(7):643-649. doi: 10.1177/0885066618773679. Epub 2018 May 2.
4
[Antithrombin III for early diagnosis of DIC in sepsis patients: a retrospective analysis with 445 patients].抗凝血酶III用于脓毒症患者弥散性血管内凝血的早期诊断:445例患者的回顾性分析
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017 Feb;29(2):127-132. doi: 10.3760/cma.j.issn.2095-4352.2017.02.007.
5
Disseminated intravascular coagulation (DIC) diagnosed based on the Japanese Association for Acute Medicine criteria is a dependent continuum to overt DIC in patients with sepsis.根据日本急性医学协会标准诊断的弥散性血管内凝血(DIC)是脓毒症患者显性DIC的一个相关连续过程。
Thromb Res. 2009 Mar;123(5):715-8. doi: 10.1016/j.thromres.2008.07.006. Epub 2008 Sep 5.
6
Comparison of Three Different Disseminated Intravascular Coagulation (DIC) Criteria and Diagnostic and Prognostic Value of Antithrombin Investigation in Patients with Confirmed Sepsis-Induced Coagulopathy (SIC).比较三种不同的弥散性血管内凝血(DIC)标准与确诊脓毒症诱导性凝血功能障碍(SIC)患者抗凝血酶研究的诊断和预后价值。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241271334. doi: 10.1177/10760296241271334.
7
Prognostic Accuracy of the Different Scoring Systems for Assessing Coagulopathy in Sepsis: A Retrospective Study.不同评分系统评估脓毒症凝血障碍的预后准确性:一项回顾性研究。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231207630. doi: 10.1177/10760296231207630.
8
Evaluation of modified non-overt DIC criteria on the prediction of poor outcome in patients with sepsis.评估改良的非显性 DIC 标准对脓毒症患者预后不良的预测价值。
Thromb Res. 2010 Jul;126(1):18-23. doi: 10.1016/j.thromres.2009.12.008. Epub 2010 Jan 18.
9
Roles of Coagulation Abnormalities and Microthrombosis in Sepsis: Pathophysiology, Diagnosis, and Treatment.凝血异常和微血栓形成在脓毒症中的作用:病理生理学、诊断和治疗。
Arch Med Res. 2021 Nov;52(8):788-797. doi: 10.1016/j.arcmed.2021.07.003. Epub 2021 Jul 31.
10
External Validation of the Two Newly Proposed Criteria for Assessing Coagulopathy in Sepsis.评估脓毒症凝血障碍的两项新提出标准的外部验证。
Thromb Haemost. 2019 Feb;119(2):203-212. doi: 10.1055/s-0038-1676610. Epub 2018 Dec 28.

引用本文的文献

1
Artificial intelligence in clinical thrombosis and hemostasis: A review.临床血栓形成与止血中的人工智能:综述
Res Pract Thromb Haemost. 2025 Jul 24;9(5):102984. doi: 10.1016/j.rpth.2025.102984. eCollection 2025 Jul.
2
Developing a molecular diagnostic model for heatstroke-induced coagulopathy: a proteomics and metabolomics approach.开发中暑诱导凝血功能障碍的分子诊断模型:蛋白质组学和代谢组学方法
Front Mol Biosci. 2025 Jun 20;12:1616073. doi: 10.3389/fmolb.2025.1616073. eCollection 2025.
3
Disseminated intravascular coagulation: cause, molecular mechanism, diagnosis, and therapy.

本文引用的文献

1
Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts.基于机器学习的冠心病标志物:在两个纵向队列中的推导和验证。
Lancet. 2023 Jan 21;401(10372):215-225. doi: 10.1016/S0140-6736(22)02079-7. Epub 2022 Dec 20.
2
Artificial intelligence for predicting survival following deceased donor liver transplantation: Retrospective multi-center study.人工智能预测脑死亡供肝移植术后患者的生存情况:回顾性多中心研究。
Int J Surg. 2022 Sep;105:106838. doi: 10.1016/j.ijsu.2022.106838. Epub 2022 Aug 24.
3
Artificial intelligence-enhanced electrocardiography in cardiovascular disease management.
弥散性血管内凝血:病因、分子机制、诊断与治疗
MedComm (2020). 2025 Jan 14;6(2):e70058. doi: 10.1002/mco2.70058. eCollection 2025 Feb.
4
The transition of the criteria for disseminated intravascular coagulation and the targeted patients in randomized controlled trials over the decades: a scoping review.几十年来随机对照试验中弥散性血管内凝血标准及目标患者的转变:一项范围综述
Thromb J. 2024 Dec 23;22(1):112. doi: 10.1186/s12959-024-00681-w.
人工智能增强心电图在心血管疾病管理中的应用
Nat Rev Cardiol. 2021 Jul;18(7):465-478. doi: 10.1038/s41569-020-00503-2. Epub 2021 Feb 1.
4
Performances of disseminated intravascular coagulation scoring systems in septic shock patients.弥散性血管内凝血评分系统在脓毒性休克患者中的表现。
Ann Intensive Care. 2020 Jul 10;10(1):92. doi: 10.1186/s13613-020-00704-5.
5
Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis.医院和 ICU 治疗的脓毒症的发病率和死亡率:一项更新和扩展的系统评价和荟萃分析的结果。
Intensive Care Med. 2020 Aug;46(8):1552-1562. doi: 10.1007/s00134-020-06151-x. Epub 2020 Jun 22.
6
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.全球、地区和国家脓毒症发病率和死亡率,1990-2017 年:全球疾病负担研究分析。
Lancet. 2020 Jan 18;395(10219):200-211. doi: 10.1016/S0140-6736(19)32989-7.
7
Artificial intelligence as an emerging technology in the current care of neurological disorders.人工智能作为当前神经系统疾病护理中的一项新兴技术。
J Neurol. 2021 May;268(5):1623-1642. doi: 10.1007/s00415-019-09518-3. Epub 2019 Aug 26.
8
Reporting of artificial intelligence prediction models.人工智能预测模型的报告。
Lancet. 2019 Apr 20;393(10181):1577-1579. doi: 10.1016/S0140-6736(19)30037-6.
9
Optimal Timing and Early Intervention With Anticoagulant Therapy for Sepsis-Induced Disseminated Intravascular Coagulation.脓毒症诱导的弥散性血管内凝血抗凝治疗的最佳时机与早期干预
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619835055. doi: 10.1177/1076029619835055.
10
External Validation of the Two Newly Proposed Criteria for Assessing Coagulopathy in Sepsis.评估脓毒症凝血障碍的两项新提出标准的外部验证。
Thromb Haemost. 2019 Feb;119(2):203-212. doi: 10.1055/s-0038-1676610. Epub 2018 Dec 28.